New Evidence is a journal for Canadian health professionals with a distinctive Canadian perspective. View it online or in print for

• coverage on abstracts from scientific conferences from all over the world
• reports on advances in rheumatology
• comments by key rheumatology professionals on Canadian practice
• discussions of supportive care issues
• profiles of Canadian patients and professionals in rheumatology

New Evidence is available in print or online, and additional material can be downloaded for presentations in PowerPoint. Join our subscribers for a free regular copy of upcoming issues. This information will be used only for the sole purpose of compiling our mailing list and will not be used for any other purpose or shared with any other organization.

Disclaimer:
New Evidence is an independent medical news reporting service providing educational updates on current medical events. Views expressed are those of the participants and do not necessarily reflect those of the publisher or the sponsor.

Sponsorship:
Support for development and distribution of this report was provided by Roche Rheumatology and was unrestricted to ensure independence. Any therapies mentioned in this report should be used in accordance with the recognized prescribing information. No claims or endorsements are made for any products, uses, or doses presently under investigation. Information provided herein is not intended to serve as the sole basis for individual care. Our objective is to facilitate understanding of current trends in rheumatology for physicians and allied healthcare providers.

Privacy:
We recognize the importance of privacy and are committed to maintaining the accuracy, confidentiality, and security of your personal information. New Evidence will not disclose your personal information to third party stakeholders (sponsors, advertisers, partners, or other clients). New Evidence will not collect any personal information without your prior consent. All personal information collected by New Evidence is stored in server sectors that are inaccessible to the public. For more information, please read the details of our Privacy Policy.